2016
DOI: 10.1007/s00262-016-1828-3
|View full text |Cite
|
Sign up to set email alerts
|

Differential immunomodulatory activity of tumor cell death induced by cancer therapeutic toll-like receptor ligands

Abstract: Synthetic toll-like receptor (TLR) ligands stimulate defined immune cell subsets and are currently tested as novel immunotherapeutic agents against cancer with, however, varying clinical efficacy. Recent data showed the expression of TLR receptors also on tumor cells. In this study we investigated immunological events associated with the induction of tumor cell death by poly(I:C) and imiquimod. A human head and neck squamous cell carcinoma (HNSCC) cell line was exposed to poly(I:C) and imiquimod, which were de… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 39 publications
0
8
0
1
Order By: Relevance
“…This cell death may be anti-tumoural in two ways: First, as a direct consequence, the number of tumour cells is reduced. Second, via a process termed ‘immunogenic cell death', additional activation of anti-tumour immunity may occur910. However, some evidence suggests that this type of immunogenic cell death may rather be associated with the effects of TLR ligands on RIG-I-like helicases11, another class of pattern recognition receptors responsive to synthetic and pathogenic nucleic acids.…”
mentioning
confidence: 99%
“…This cell death may be anti-tumoural in two ways: First, as a direct consequence, the number of tumour cells is reduced. Second, via a process termed ‘immunogenic cell death', additional activation of anti-tumour immunity may occur910. However, some evidence suggests that this type of immunogenic cell death may rather be associated with the effects of TLR ligands on RIG-I-like helicases11, another class of pattern recognition receptors responsive to synthetic and pathogenic nucleic acids.…”
mentioning
confidence: 99%
“…In addition to U1, other RNAs that are released from damaged tissue could serve as endogenous ligands for TLR3 through their secondary structures [ 45 ]. Moreover, cancer therapeutic RNA compounds induce cell death in tumors and serve as TLR3 ligands [ 46 ]. Therefore, identification of specific alterations in noncoding RNA induced by cocaine exposure may help to determine the mechanism of TLR3 activation and downstream NF-κB signaling.…”
Section: Discussionmentioning
confidence: 99%
“…For LRYM_T versus LRYM_N, DEGs were up-regulated mainly in protein digestion and absorption and cytokine-cytokine receptor interaction; and DEGs were down-regulated mainly in ECM-receptor interaction. CXCL1, CXCL3, and CXCL5 were up-regulated; CXCL1, CXCL3, and CXCL5 are known to contribute to the invasion and metastasis [17,18]. Collagen, THBS, and fibronectin are known to contribute to ECM-receptor interaction, which is down-regulated.…”
Section: Discussionmentioning
confidence: 99%